Ambarella Introduces CV5 High Performance AI Vision Processor for Single 8K and Multi-Imager AI Cameras
Ambarella, Inc. (Nasdaq: AMBA), an AI vision silicon company, today unveiled CV5, an artificial intelligence (AI) vision processor capable of recording 8K video or four 4K video streams. The new system on chip (SoC) will enable the development of intelligent automotive camera systems, consumer cameras (drone, action, and 360°), and robotic cameras. It combines Ambarella’s powerful CVflow AI engine with dual Arm® A76 CPUs to provide the performance necessary for a wide range of AI-based algorithms. Its advanced image signal processor (ISP) can simultaneously process images for both human viewing and machine processing. Fabricated in advanced 5 nm process technology, CV5 consumes under 2 watts of power while encoding full 8K video at 30 frames per second.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111005235/en/
Ambarella today unveiled the CV5 AI vision CVflow® 5 nm processor for single 8K and multi-imager AI cameras, setting a new standard for power efficiency with 8K video recording in under 2 watts. The SoC targets intelligent automotive camera systems, consumer cameras (drone, action, and 360°), and robotic cameras. (Photo: Business Wire)
“With the introduction of CV5, Ambarella is defining the next generation of automotive, consumer, and robotic cameras,” said Fermi Wang, CEO of Ambarella. “By combining 8K single-channel and 4K multi-channel recording with the high performance of our CVflow AI engine, we are enabling cameras with the highest-quality imaging and innovative new AI features.”
In automotive video telematics applications, CV5 provides the performance necessary to encode multiple video streams from front ADAS, driver monitoring, cabin monitoring, and side-view cameras. Its CVflow AI engine can simultaneously run advanced driver assistance systems (ADAS) algorithms such as lane departure, and forward collision warning as well as driver monitoring algorithms such as drowsy driver detection. The combination of high-resolution video capture with advanced AI processing enables ADAS cameras to recognize images over long distances and with high accuracy.
The exceptionally low power consumption of the CV5 SoC also makes it an ideal solution for the next generation of high resolution and high frame-rate action, 360°, and virtual reality (VR) cameras, offering 8K recording and playback in very small form factor designs.
In robotic and drone applications, CV5’s CVflow AI engine can accelerate simultaneous localization and mapping (SLAM), path planning, and obstacle detection, and avoidance algorithms for navigation and autonomous operation. For drone-based aerial videography and cinematography, CV5 can simultaneously perform flight control and navigation functions while recording up to 8K resolution video recording at 60 frames per second.
The CV5 SoC shares common SDK and computer vision (CV) tools with Ambarella’s other CVflow SoC families, simplifying development of cameras with multiple price and performance options. A complete set of CV tools helps customers port their own neural networks onto CV5, including a compiler, debugger, and support for industry-standard machine learning frameworks, such as PyTorch™, ONNX™, Caffe™, and TensorFlow™, as well as extensive guidelines for convolutional neural network (CNN) performance optimization.
CV5 SoC key features:
- CVflow architecture with DNN support
- Dual-core Arm® Cortex®-A76 up to 1.6 GHz with NEON™ DSP extensions and FPU
- High-speed SLVS-EC, MIPI-CSI (C/D PHY) interfaces, connecting up to 14 cameras
- Multi-channel ISP with up to 8KP60 throughput
- Native support for RGGB, RCCB, RCCC, RGB-IR, and monochrome sensor formats
- Multi-exposure high dynamic range (HDR) processing
- Real-time, hardware-accelerated fisheye dewarping and lens distortion correction (LDC)
- AVC and HEVC encoding with up to 8KP60 throughput and multiple stream support
- Rich set of interfaces includes 4-lane PCIe, CAN FD, Gigabit Ethernet, USB 3.1 host and device, three SD card controllers, MIPI DSI/CSI-2 and HDMI video outputs
- LPDDR4x / LPDDR5 / LPDDR5x support, 64-bit data bus and up to 32 GB capacity
- Advanced security features, including secure boot with TrustZone® and secure memory, TRNG, OTP, DRAM scrambling and virtualization
- 5 nm process technology
- 16x16 FBGA package with 0.5 mm ball pitch
About Ambarella, Inc.
Ambarella’s products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and robotic applications. Ambarella’s low-power system on chips (SoCs) offer high-resolution video compression, advanced image processing, and powerful deep neural network processing to enable intelligent cameras to extract valuable data from high-resolution video streams. For more information, please visit www.ambarella.com
All brand names, product names, or trademarks belong to their respective holders. Ambarella reserves the right to alter product and service offerings, specifications and pricing at any time without notice. © 2021 Ambarella, Inc. All rights reserved.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005235/en/
Contact information
Ambarella Contact: www.ambarella.com/about/contact/inquiries
Media Contact: Molly McCarthy, Valley Public Relations, mmccarthy@ambarella.com
Investor Relations Contact: Louis Gerhardy, Ambarella, lgerhardy@ambarella.com, (408) 636-2310
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom